Cresco Labs Inc. (CRLBF)

Market Cap	375.61M
Revenue (ttm)	726.35M
Net Income (ttm)	-67.43M
Shares Out	n/a
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	202,159
Open	1.130
Previous Close	1.150
Day's Range	1.090 - 1.150
52-Week Range	1.018 - 2.650
Beta	1.97
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,760
• Stock Exchange: OTCMKTS
• Ticker Symbol: CRLBF

Financial Performance

In 2023, Cresco Labs's revenue was $756.06 million, a decrease of -8.35% compared to the previous year's $824.93 million. Losses were -$175.52 million, -17.22% less than in 2022.